Buddhism and neuroethics: the ethics of pharmaceutical cognitive enhancement.
Andrew Fenton
Developing world bioethics August 2009 DOI: 10.1111/j.1471-8847.2007.00226.x (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Topics | Buddhism |
| Key points | Argues that Buddhist concerns about harms to research subjects, karmic interference, artificiality, and user intentions do not adequately ground a reflective Buddhist opposition to pharmaceutical cognitive enhancement. Proposes that Buddhists, especially in Mahāyāna traditions, should advocate enhancement when it furthers insight into self-nature or reduces duhkha. |
Abstract
This paper integrates some Buddhist moral values, attitudes and self-cultivation techniques into a discussion of the ethics of cognitive enhancement technologies - in particular, pharmaceutical enhancements. Many Buddhists utilize meditation techniques that are both integral to their practice and are believed to enhance the cognitive and affective states of experienced practitioners. Additionally, Mahāyāna Buddhism's teaching on skillful means permits a liberal use of methods or techniques in Buddhist practice that yield insight into our selfnature or aid in alleviating or eliminating duhkha (i.e. dissatisfaction). These features of many, if not most, Buddhist traditions will inform much of the Buddhist assessment of pharmaceutical enhancements offered in this paper. Some Buddhist concerns about the effects and context of the use of pharmaceutical enhancements will be canvassed in the discussion. Also, the author will consider Buddhist views of the possible harms that may befall human and nonhuman research subjects, interference with a recipient's karma, the artificiality of pharmaceutical enhancements, and the possible motivations or intentions of healthy individuals pursuing pharmacological enhancement. Perhaps surprisingly, none of these concerns will adequately ground a reflective Buddhist opposition to the further development and continued use of pharmaceutical enhancements, either in principle or in practice. The author argues that Buddhists, from at least certain traditions - particularly Mahāyāna Buddhist traditions - should advocate the development or use of pharmaceutical enhancements if a consequence of their use is further insight into our self-nature or the reduction or alleviation of duhkha.
Comparable studies
Other theoretical and historical papers on buddhism, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Mental balance and well-being: Building bridges between Buddhism and Western psychology. | 2006 | Theoretical or philosophical paper | |
| Buddhist Modernism and the Rhetoric of Meditative Experience | 1995 | Theoretical or philosophical paper | |
| Buddhist and Psychological Perspectives on Emotions and Well-Being | 2005 | Theoretical or philosophical paper | |
| Too Early to Tell: The Potential Impact and Challenges—Ethical and Otherwise—Inherent in the Mainstreaming of Dharma in an Increasingly Dystopian World | 2017 | Theoretical or philosophical paper | |
| From self to nonself: The Nonself Theory | 2016 | Theoretical or philosophical paper |